Form 4: PepGen Inc. Insider Sells Shares to Cover Taxes

PepGen Inc. Chief Technical Officer Kasra Kasraian sold 1,233 shares of common stock to cover tax withholding obligations upon the vesting of restricted stock units.

Summary

• Kasra Kasraian, Chief Technical Officer of PepGen Inc., reported a transaction involving 1,233 shares of common stock on May 21, 2026.
• These shares were automatically sold by the Company to cover mandatory tax withholding obligations due to the vesting and settlement of restricted stock units (RSUs).
• This sale was executed under a pre-existing binding contract consistent with Rule 10b5-1(c) and does not represent a discretionary trade.
• The shares were sold at a weighted average price of $1.41, with individual transactions ranging from $1.41 to $1.4541.
• Following this transaction, Kasraian beneficially owns 50,074 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a standard, pre-planned, and mandatory event for tax coverage rather than a reflection of the insider's view on the company's prospects.

Positives

• The transaction was conducted under a Rule 10b5-1(c) plan, indicating pre-planned and compliant trading activity.
• The sale was mandatory to cover tax obligations, not a discretionary decision to divest shares.
• The reporting person retains a significant number of shares (50,074) after the transaction.

Negatives

• A portion of the reporting person's vested shares were sold, reducing their direct holdings.

Risks

• The filing does not explicitly mention any new or emerging risks.
• The sale of shares, even if mandatory, could be perceived negatively by the market if not clearly understood as a tax-related event.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it pertains to a specific insider transaction.

Management Comments

• The mandatory sale of the Reporting Person's shares was provided for in a RSU agreement constituting a 'binding contract' consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. The specific nature of this transaction, a mandatory sell-to-cover for tax obligations under a 10b5-1 plan, is a common and generally accepted practice within the biopharmaceutical industry, which often involves significant equity-based compensation.

Stakeholder Impact

• Shareholders: The transaction is unlikely to have a significant impact as it was a pre-planned, mandatory sale to cover taxes, not a discretionary sale based on company performance. The reporting person retains a substantial number of shares.
• Employees: This filing highlights the standard practice of equity compensation and associated tax obligations for key personnel.
• Management: Reinforces the established compensation and trading policies within the company.

Next Steps

• No specific next steps are outlined in this filing beyond the completion of the reported transaction.

Key Dates

Keywords

Form 4, Insider Trading, PepGen Inc., PEPG, Restricted Stock Units, RSU Vesting, Tax Withholding, Rule 10b5-1, Stock Sale, Beneficial Ownership